Latest NewsIn its decision in American Needle Inc. v. National Football League on May 24, 2010, the United States Supreme Court unanimously held that an association formed by the member teams of the National Football League (NFL) to market their intellectual property rights collectively should be treated, for anti-trust law purposes, as a “combination” rather than a single entity. More …. Two February 2010 decisions of the Enlarged Board of Appeal of the European Patent Office (EPO) have added some clarity as to what is patent eligible subject matter in the field of medical inventions where there was previously some conflict between prior decisions of the technical boards of appeal. The two cases were decided were G2/08 (Dosage regime/Abbott Respiratory) and G1/07 (Treatment by surgery/Medi-Physics). More …. The recent health care reform legislation in the United States has taken steps to fill what some have seen as an anomaly the inter play between drug regulation and the patent law in that certain provisions that relate to small molecule drugs do not apply to biological drugs (essentially, those made in living cells rather than by chemical synthesis). The recent health care reform legislation addresses this. More …. On March 29, 2010, in a controversial decision which, if upheld on appeal, could have far-reaching implications for the biotechnology industry in the United States, the District Court for the Southern District of New York held that isolated genes do not constitute patent eligible subject matter. Judge Sweet in making this ruling in the case of Association for Molecular Pathology v. United States Patent and Trademark Office, also held that claims to analyzing and comparing genes failed to meet the statutory criteria for patentability. More …. Creating, registering and protecting trademark rights can be a costly undertaking, whether on behalf of a large corporation’s international portfolio or the single brand of a small business. In the present weak economy trademark owners should consider ways in which costs may be reduced by working more efficiently with outside counsel, improving the predictability of costs, and investing in the long-term protection of intellectual property assets necessary to add real value to their undertakings. More …. |
Ladas & Parry LLP is an international law firm with over 90 years of experience protecting its clients' intellectual property in the United States and abroad. With offices in Chicago, Los Angeles, New York, London and Munich, we serve clients across the globe, from numerous Fortune 100 companies to small and medium-sized enterprises across a broad spectrum of industries, to entrepreneurs, entertainers and celebrities.
Our comprehensive knowledge of global intellectual property law, our moderate size that facilitates personalized service and close attorney-client relationships, and our dedication to client service has kept us in the forefront of our profession for nearly 95 years. As part of our extensive involvement in the international intellectual property community, we are also proud to sponsor the Ladas Memorial Award, in memory of the outstanding contributions to international intellectual property law made by our late partner the distinguished practitioner and author, Dr. Stephen P. Ladas. The Award is presented each year by the Brand Names Education Foundation to the paper judged best on the subject of trademark law or a matter that directly relates to or affects trademarks. No attorney-client relationship is created by accessing this website (or any of our related websites to which you may be referred by this website). You are free to contact us by e-mail, telephone, fax, regular mail or in person, if you so desire, but please be aware that we will first conduct a conflict check before giving consideration to accepting you as a new client. Moreover, if we do accept you as a new client, it will only be pursuant to a written retainer agreement executed by both parties. In the absence of a written retainer agreement, any information we provide to you in response to an inquiry or otherwise should not be considered legal advice and you should not rely on it as if it were. We have well over a thousand pages of legal information at this web site. We hope that you find the information useful. However, if you have a legal issue which is important to you, these pages are no substitute for competent legal advice. Please read our disclaimer. |
Ladas & Parry LLP has 50+ US attorneys, foreign attorneys, patent agents, and professional representatives in our offices. Our practice is broad-ranging, from all aspects of patent, trademark, and copyright law and litigation, to advice on entertainment law, domain names, security interests in intellectual property, licensing, franchising and related aspects of commercial law and other legal areas dealing with technology.
[Home] [About Ladas &
Parry LLP] [Contact Us] [Search]
[Trademarks] [Domain
Names & E-Commerce] [Patents & Copyrights]
[Litigation] [IP
Rights Maintenance] [IP as Property]
[News & Bulletins]
© Copyright 2009 Ladas & Parry - Updated on
6/16/2010
Please read our disclaimer.
Date & time viewed:
